Abstract
Complex technical, administrative, and clinical steps involving multiple staff members and various materials and other resources must be successfully completed for a blood transfusion to be given and properly managed. These factors are responsible for the direct and indirect costs of transfusion, which are often overlooked and vastly underestimated. In this study, the total cost of red blood cell (RBC) transfusion process in the surgical setting was calculated through activity-based costing (ABC) in a US hospital as a part of the Cost-of-Blood Consensus Conference (COBCON) project, sponsored by the Society for the Advancement of Blood Management (SABM;
Table: Transfusion-related processes with highest usage factor in surgical setting. Not all processes are listed.
Main processes . | Usage factor/frequency . |
---|---|
Explaining transfusion risk and obtaining informed consent | 13,233 |
Pre-transfusion examination & clerical routine | >2,413 |
Phlebotomzig & delivering patient’s blood specimen to blood bank & central lab | >2,485 |
Patient blood testing in central lab & analyzing results - routine & emergency | >2,413 |
Controlling & storing components in hospital blood bank | 1,445 |
ABO/Rh-typing new patients | >1,330 |
ABO/Rh-typing control | >2,413 |
Antibody screening | >2,413 |
Cross matching | 4,028 |
manual distribution of components and controlling delivery received at transfusion site | 1779 |
Return deliveries of unused components | 633 |
Cleaning transfusion site & disposing waste | >455 |
Administering and monitoring transfusion | 1368 |
Main processes . | Usage factor/frequency . |
---|---|
Explaining transfusion risk and obtaining informed consent | 13,233 |
Pre-transfusion examination & clerical routine | >2,413 |
Phlebotomzig & delivering patient’s blood specimen to blood bank & central lab | >2,485 |
Patient blood testing in central lab & analyzing results - routine & emergency | >2,413 |
Controlling & storing components in hospital blood bank | 1,445 |
ABO/Rh-typing new patients | >1,330 |
ABO/Rh-typing control | >2,413 |
Antibody screening | >2,413 |
Cross matching | 4,028 |
manual distribution of components and controlling delivery received at transfusion site | 1779 |
Return deliveries of unused components | 633 |
Cleaning transfusion site & disposing waste | >455 |
Administering and monitoring transfusion | 1368 |
Disclosures: Shander:Ortho Biotech: Consultancy, Honoraria, Research Funding; Amgen: Consultancy, Honoraria, Research Funding.
Author notes
Corresponding author
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal